Does recreational ecstasy use cause long-term cognitive problems?

Western Journal of Medicine

Volumn 173, Issue 2, 2000, Pages 129-130

  Kelly, P A T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL CELL; ANIMAL TISSUE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DRUG ABUSE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MENTAL STRESS; NEUROTOXICITY; NONHUMAN; REVIEW;

ANIMALS; COGNITION DISORDERS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; RISK FACTORS; STREET DRUGS;

EID: 0033836455     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.173.2.129     Document Type: Review

References (28)

1. Better than well
2. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of [3H]-labelled serotonin uptake sites
3. 5-Hydroxyindolacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates
4. MDMA selectively damages central serotonergic neurons in the primate
5. 5-HT Loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine
6. Relationship between the dose of MDMA and frequency, of administrationon the subsequent neurodegeneration of rat brain 5-HT
7. Studies of MDMA-induced neurotoxicity in non-human primates: A basis for evaluating long-term effects in humans
8. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ('Ecstasy')
9. Chronic 3,4-methylenedioxymethamphetamine (MDMA) administration decreases glucocorticoid and mineralocorticoid receptor, but increases 5-HT1C receptor gene expression in the rat hippocampus
10. Site-specific regulation of corticoid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: Role of corticosterone and serotonin
11. 3,4-Methylenedioxymethamphetamine, serotonin and memory
12. Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat
13. Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
14. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users: A controlled study
15. Ecstasy - Long-term effects on the human central nervous system revealed by positron emission tomography
16. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users
17. Memory disturbances in 'ecstasy' users are correlated with an altered brain serotonin neurotransmission
18. Memory impairment in abstinent MDMA ('ecstasy') users
19. Impaired cognitive performance in drag free users of recreational ecstasy
20. Blasted by ecstasy: Psychopathological implications of the loss of serotonergic axon terminals caused by substituted amphetamines
21. Clinical and toxicological aspects of ecstasy (XTC) use
22. Central serotonergic nerves project to the pial vessels of the brain
23. Experimental neocortical hyperemia produced by acute exposure to methylenedioxymethamphetamine
24. 'Ecstasy' and intracerebral haemorrhage
25. Enhanced cerebrovascular responsiveness to hypercapnia following depletion of central serotonergic terminals
26. Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
27. Mood and cognitive effects of +/- 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
28. Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects